For Founders

Build With Us

Splice is for founders building at the intersection of AI and programmable capital. We provide the infrastructure, validation frameworks, and GTM machinery—you keep the agency and ownership.

Who Should Apply

Technical or domain expertise in agentic finance, stablecoin infrastructure, or governed autonomous systems

An idea at the concept or early validation stage—we help shape, not rescue

Willingness to work within our validation frameworks and evidence-first methodology

Long-term vision aligned with governed autonomous capital thesis

What Splice Contributes

Research

Market validation, competitive analysis, regulatory landscape mapping

Architecture

System design, protocol architecture, security modeling

Technical Scaffolding

MVP frameworks, HELIOS integration, governed agent infrastructure

GTM

Go-to-market strategy, pilot programs, institutional partnerships

Fundraising Prep

Deck development, investor intros, diligence preparation

What Founders Keep

Agency

You make the calls. We provide infrastructure, not mandates.

Majority Ownership

93% founder equity in co-incubation model. Clean cap tables.

Company Independence

Your company. Your board. No platform lock-in.

Frequently Asked Questions

What equity does Splice take?

In our 93/7 co-incubation model, founders retain 93% and Splice takes 7%. This is negotiated based on contribution and timing.

Are there platform fees?

No mandatory platform fees. You don't pay to use HELIOS infrastructure. Our return comes from equity participation.

Do you provide cofounders?

We can help recruit from our operator bench, but we don't force cofounder matches. Team building is collaborative.

What about board seats?

We don't require board seats at early stages. Governance is appropriate to stage and negotiated transparently.

Who owns the IP?

The company owns all IP generated during incubation. HELIOS infrastructure is licensed, not transferred.

What's the typical timeline?

Validation to prototype: variable based on domain complexity. We optimize for evidence, not arbitrary deadlines.